Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Brain : a journal of neurology

• Publication date

  2014-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/brain/awt360PMID 24480486PMCID PMC3983409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease

  2014influential reference
• Visual Hallucinations in PD and Lewy Body Dementias: Old and New Hypotheses

  2013influential reference
• Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease.

  2013influential reference
• Retinal Nerve Fiber Layer Thinning in Dementia Associated with Parkinson's Disease, Dementia with Lewy Bodies, and Alzheimer's Disease

  2013cited by this paper
• Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease?

  2013cited by this paper
• Neuroanatomy of auditory verbal hallucinations in schizophrenia: a quantitative meta-analysis of voxel-based morphometry studies.

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease

  2012influential reference
• Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

  2012cited by this paper
• Clinical differences among mild cognitive impairment subtypes in Parkinson's disease

  2012cited by this paper
• Increased levels of 5‐HT1A receptor binding in ventral visual pathways in Parkinson's disease

  2012cited by this paper
• Organization of the Human Inferior Parietal Lobule Based on Receptor Architectonics

  2012cited by this paper
• The pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-based morphometry study

  2011influential reference
• Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years

  2011cited by this paper
• Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks?

  2011influential reference
• Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study

  2011cited by this paper
• Update on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative

  2010cited by this paper
• Dementia with Lewy bodies and Alzheimer disease

  2010cited by this paper
• Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations

  2010cited by this paper
• A 12-year population-based study of psychosis in Parkinson disease.

  2010cited by this paper
• Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia

  2010influential reference
• Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.

  2009influential reference
• The retina in Parkinson's disease.

  2009cited by this paper
• Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations

  2009influential reference
• Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease

  2008cited by this paper
• Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

  2008influential reference
• Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia

  2008influential reference
• Nicotinic α4β2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations

  2008cited by this paper
• Clinical diagnostic criteria for dementia associated with Parkinson's disease

  2007cited by this paper
• A fast diffeomorphic image registration algorithm

  2007cited by this paper
• Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group

  2007influential reference
• Cerebral atrophy in Parkinson's disease patients with visual hallucinations

  2007influential reference
• Metabolic alterations in patients with Parkinson disease and visual hallucinations.

  2007influential reference
• Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations.

  2006cited by this paper
• Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations

  2006cited by this paper
• Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model

  2005influential reference
• Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years

  2005cited by this paper
• Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations

  2005influential reference
• Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations

  2005cited by this paper
• Altered cortical visual processing in PD with hallucinations

  2004influential reference
• Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

  2003cited by this paper
• Chlorpromazine equivalent doses for the newer atypical antipsychotics.

  2003cited by this paper
• Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.

  2002cited by this paper
• A voxel-based morphometric study of ageing in 465 normal adult human brains

  2001cited by this paper
• Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study

  2000cited by this paper
• Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.

  2000influential reference
• The perceptual consequences of visual loss: 'positive' pathologies of vision.

  1999cited by this paper
• Medication-induced hallucination and cerebral blood flow in Parkinson’s disease

  1999cited by this paper
• Poor visual discrimination and visual hallucinations in Parkinson's disease.

  1998cited by this paper
• Mortality and hallucinations in nursing home patients with advanced Parkinson's disease

  1995cited by this paper
• A clinicopathologic study of 100 cases of Parkinson's disease.

  1993cited by this paper
• The Clinical Dementia Rating (CDR)

  1993cited by this paper
• Separate visual pathways for perception and action.

  1992cited by this paper
• The medial temporal lobe memory system

  1991cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975influential reference

• Cholinergic neurotransmission underlying visual hallucinations in Parkinson's disease: Integration of multimodal evidence and translational approaches.

  2026cites this paper
• Resolution of Visual Hallucinations in Parkinson’s Disease After Right Occipitoparietal Subcortical Hemorrhage: A Case Report

  2026cites this paper
• Investigation of Normalized Volume Ratios of Motor and Sensory Cortices on Magnetic Resonance Images in Parkinson's Disease Patients: An Automatic Brain Segmentation Study

  2025cites this paper
• Visual hallucinations in Parkinson's disease are associated with deficits in social perception

  2025cites this paper
• Impact of Arteriovenous Malformations in the Precentral and Postcentral Gyri on Intracranial Volumes.

  2025cites this paper
• Brain functional network abnormalities in Parkinson’s disease patients at different disease stages

  2025cites this paper
• Impacto de las malformaciones arteriovenosas en los giros precentral y poscentral sobre los volúmenes intracraneales

  2025cites this paper
• The Claustrum and Its Role in Neurodegenerative Diseases-A Narrative Review.

  2025cites this paper
• Changes of brain structure and structural covariance networks in Parkinson’s disease with different sides of onset

  2025cites this paper
• Shared and distinct cortical morphometric alterations in five neuropsychiatric symptoms of Parkinson’s disease

  2024cites this paper
• Exploring the relationship between hallucination proneness and brain morphology

  2024cites this paper
• Visual hallucinations in Parkinson’s disease: spotlight on central cholinergic dysfunction

  2024cites this paper
• Distinct grey and white matter changes are associated with the phenomenology of visual hallucinations in Lewy Body Disease

  2024influential citation
• Psychotic disorders in Parkinson's disease: phenomenology, pathogenesis, therapeutic approaches (modern view on the problem)

  2024cites this paper
• Self-reported Visual Difficulty, Age-related Eye Disease, and Neuropsychiatric Outcomes in Older Adults

  2024cites this paper
• Deterioration of fine motor skills and functional disability in patients with moderate-to-advanced Parkinson disease: A longitudinal follow-up study.

  2024cites this paper
• A general clinical overview of the non-motor symptoms in Parkinson's disease: Neuropsychiatric symptoms.

  2024cites this paper
• Parkinson disease psychosis: from phenomenology to neurobiological mechanisms

  2024cites this paper
• Cognitive and executive impairments in Parkinson’s disease psychosis: a Bayesian meta-analysis

  2023cites this paper
• Grey matter volume loss in Parkinson's Disease Psychosis and its relationship with serotonergic gene expression: A meta-analysis.

  2023cites this paper
• Volumetric changes and clinical trajectories in Parkinson’s disease: a prospective multicentric study

  2023cites this paper
• Visual Dysfunction in Parkinson’s Disease

  2023influential citation
• Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature

  2023cites this paper
• Neuropsychological correlates of visual hallucinatory phenomena in Lewy body disease

  2023cites this paper
• Theta oscillations and minor hallucinations in Parkinson’s disease reveal decrease in frontal lobe functions and later cognitive decline

  2022cites this paper
• Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinations

  2022cites this paper
• Baseline free water within the visual processing system predicts future psychosis in Parkinson disease

  2022cites this paper
• Cerebral neurovascular alterations in stable chronic obstructive pulmonary disease: a preliminary fMRI study

  2022cites this paper
• Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease

  2022cites this paper
• Management of psychiatric and cognitive complications in Parkinson’s disease

  2022cites this paper
• Gray matter, white matter and cerebrospinal fluid abnormalities in Parkinson’s disease: A voxel-based morphometry study

  2022cites this paper
• Emerging role of psychosis in Parkinson's disease: From clinical relevance to molecular mechanisms

  2022cites this paper
• Aberrant gray matter volume and functional connectivity in Parkinson’s disease with minor hallucination

  2022cites this paper
• The role of attentional control over interference in minor hallucinations in Parkinson's disease.

  2022cites this paper
• Modulation of cortical resting state functional connectivity during a visuospatial attention task in Parkinson's disease

  2022cites this paper
• Identifying and validating subtypes of Parkinson's disease based on multimodal MRI data via hierarchical clustering analysis

  2022cites this paper
• Psychosis in Parkinson's Disease: Looking Beyond Dopaminergic Treatments.

  2022cites this paper
• Resting-State Functional Network Topology Alterations of the Occipital Lobe Associated With Attention Impairment in Isolated Rapid Eye Movement Behavior Disorder

  2022cites this paper
• Magnetoencephalography detects phase-amplitude coupling in Parkinson’s disease

  2022cites this paper
• Structural and Functional Correlates of Hallucinations and Illusions in Parkinson’s Disease

  2021cites this paper
• Dopaminergic Basis of Spatial Deficits in Early Parkinson's Disease.

  2021cites this paper
• Magnetoencephalography-detected Phase-amplitude Coupling in Parkinson Disease

  2021cites this paper
• Tipping the scales: how clinical assessment shapes the neural correlates of Parkinson’s disease mild cognitive impairment

  2021cites this paper
• Knowledge domain and emerging trends in visual hallucination research: A scientometric analysis

  2021cites this paper
• Altered microstructural properties of superficial white matter in patients with Parkinson’s disease

  2021cites this paper
• Alterations in functional network centrality in first-episode drug-naïve adolescent-onset schizophrenia

  2021cites this paper
• [Visual hallucinations in Parkinson's disease].

  2021cites this paper
• Neuroanatomical and cognitive correlates of visual hallucinations in Parkinson's disease and dementia with Lewy bodies: Voxel-based morphometry and neuropsychological meta-analysis.

  2021cites this paper
• Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy

  2021cites this paper
• Cognitive Correlates of Visual and Minor Hallucinations in Parkinson’s Disease

  2021cites this paper
• Patterns of Sulcal depth and cortical thickness in Parkinson’s disease

  2021cites this paper
• Psychosis and Parkinson’s Disease

  2021cites this paper
• Will Artificial Intelligence Outperform the Clinical Neurologist in the Near Future? No

  2021cites this paper
• Disrupted morphological grey matter networks in early-stage Parkinson’s disease

  2021cites this paper
• Mapping brain structural differences and neuroreceptor correlates in Parkinson's disease visual hallucinations: a mega-analysis

  2021cites this paper
• Psychosis in Parkinson disease

  2020cites this paper
• ALFF and ReHo Mapping Reveals Different Functional Patterns in Early- and Late-Onset Parkinson’s Disease

  2020cites this paper
• Abnormalities in the white matter tracts in patients with Parkinson disease and psychosis

  2020cites this paper
• Pharmacotherapy of Psychosis in Parkinson’s Disease

  2020cites this paper
• Neuroimaging Findings in Patients with Hallucinations: Evidence from Neurodegenerative and Psychiatric Conditions

  2020cites this paper
• Studies on the Bottom-Up and Top-Down Neural Information Flow Alterations in Neurodegeneration

  2020cites this paper
• Differential Changes in Arteriolar Cerebral Blood Volume between Parkinson’s Disease Patients with Normal and Impaired Cognition and Mild Cognitive Impairment (MCI) Patients without Movement Disorder – An Exploratory Study

  2020cites this paper
• Increasing Contrast Improves Object Perception in Parkinson's Disease with Visual Hallucinations

  2020cites this paper
• Minor hallucinations reflect early gray matter loss and predict subjective cognitive decline in Parkinson's disease

  2020cites this paper
• COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly

  2020cites this paper
• Ocular fixations and presaccadic potentials to explain pareidolias in Parkinson’s disease

  2020cites this paper
• Management of psychiatric disorders in Parkinson’s disease

  2020cites this paper
• Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology

  2020cites this paper
• Vision loss and hallucinations: perspectives from neurology and ophthalmology

  2020cites this paper
• Psychosis in Parkinson's Disease

  2020cites this paper
• Association of Preoperative Visual Hallucinations With Cognitive Decline After Deep Brain Stimulation for Parkinson's Disease.

  2020cites this paper
• Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease

  2020cites this paper
• Visual hallucinations and inferior longitudinal fasciculus in Parkinson's disease

  2020cites this paper
• The Pharmacology of Visual Hallucinations in Synucleinopathies

  2019cites this paper
• The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

  2019cites this paper
• Increased Cortical Thickness in Attentional Networks in Parkinson's Disease with Minor Hallucinations

  2019cites this paper
• Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up.

  2019cites this paper
• Minor hallucinations in Parkinson disease

  2019cites this paper
• Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson’s disease

  2019cites this paper
• Cingulate cortex in Parkinson's disease.

  2019cites this paper
• Grey matter abnormalities in Parkinson’s disease: a voxel‐wise meta‐analysis

  2019cites this paper
• Visual Hallucinations and Impaired Conscious Visual Perception in Parkinson Disease

  2019influential citation
• Cognitive correlates of cerebellar resting-state functional connectivity in Parkinson disease

  2019cites this paper
• Structural alteration of motor and sensory cortices in Parkinson’s disease using magnetic resonance imaging: Automatic brain segmentation

  2018cites this paper
• Severe hyposmia and aberrant functional connectivity in cognitively normal Parkinson’s disease

  2018cites this paper
• Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson's disease

  2018cites this paper
• White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease

  2018cites this paper
• Imaging of Motor Cortex Physiology in Parkinson's Disease

  2018cites this paper
• Meta-analytic Evidence for the Plurality of Mechanisms in Transdiagnostic Structural MRI Studies of Hallucination Status

  2018cites this paper
• Reduced occipital GABA in Parkinson disease with visual hallucinations

  2018cites this paper
• Impaired topographic organization in cognitively unimpaired drug-naïve patients with rigidity-dominant Parkinson's disease.

  2018cites this paper
• Brain degeneration in Parkinson’s disease patients with cognitive decline: a coordinate-based meta-analysis

  2018cites this paper
• Hippocampal subfield atrophy in patients with Parkinson’s disease and psychosis

  2018cites this paper
• Regional expression of genes mediating trans-synaptic alpha-synuclein transfer predicts regional atrophy in Parkinson disease

  2018cites this paper
• Evaluation of visual hallucination based on pareidolia testing in patients with Alzheimer’s Disease

  2018cites this paper
• Can deep brain stimulation of the nucleus basalis of Meynert improve thinking and memory problems in Lewy body dementias

  2017cites this paper
• Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

  2017cites this paper
• The Relationship Between Serotonin‐2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations

  2017cites this paper
• Structural and Functional Neuroimaging of Visual Hallucinations in Lewy Body Disease: A Systematic Literature Review

  2017influential citation
• Imaging behavioural complications of Parkinson’s disease

  2017cites this paper